JP2017516785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516785A5 JP2017516785A5 JP2016569636A JP2016569636A JP2017516785A5 JP 2017516785 A5 JP2017516785 A5 JP 2017516785A5 JP 2016569636 A JP2016569636 A JP 2016569636A JP 2016569636 A JP2016569636 A JP 2016569636A JP 2017516785 A5 JP2017516785 A5 JP 2017516785A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- cancer
- salt according
- autoimmune
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2596CH2014 | 2014-05-27 | ||
| IN2597/CHE/2014 | 2014-05-27 | ||
| IN2596/CHE/2014 | 2014-05-27 | ||
| IN2597CH2014 | 2014-05-27 | ||
| PCT/IB2015/053940 WO2015181728A1 (en) | 2014-05-27 | 2015-05-26 | Improved forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020088147A Division JP2020122022A (ja) | 2014-05-27 | 2020-05-20 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017516785A JP2017516785A (ja) | 2017-06-22 |
| JP2017516785A5 true JP2017516785A5 (enExample) | 2017-08-03 |
| JP6987501B2 JP6987501B2 (ja) | 2022-01-05 |
Family
ID=53499042
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016569636A Expired - Fee Related JP6987501B2 (ja) | 2014-05-27 | 2015-05-26 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
| JP2020088147A Pending JP2020122022A (ja) | 2014-05-27 | 2020-05-20 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
| JP2022062937A Pending JP2022082680A (ja) | 2014-05-27 | 2022-04-05 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020088147A Pending JP2020122022A (ja) | 2014-05-27 | 2020-05-20 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
| JP2022062937A Pending JP2022082680A (ja) | 2014-05-27 | 2022-04-05 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US9969740B2 (enExample) |
| EP (2) | EP3971188A1 (enExample) |
| JP (3) | JP6987501B2 (enExample) |
| KR (1) | KR20170007480A (enExample) |
| CN (2) | CN106661030B (enExample) |
| AU (1) | AU2015265542B2 (enExample) |
| BR (1) | BR112016027674A2 (enExample) |
| CA (1) | CA2949932C (enExample) |
| CY (1) | CY1124316T1 (enExample) |
| DK (1) | DK3149000T3 (enExample) |
| EA (1) | EA032506B1 (enExample) |
| ES (1) | ES2880999T3 (enExample) |
| HR (1) | HRP20211151T1 (enExample) |
| HU (1) | HUE054916T2 (enExample) |
| IL (1) | IL249058B2 (enExample) |
| LT (1) | LT3149000T (enExample) |
| PL (1) | PL3149000T3 (enExample) |
| PT (1) | PT3149000T (enExample) |
| RS (1) | RS62136B1 (enExample) |
| SI (1) | SI3149000T1 (enExample) |
| SM (1) | SMT202100532T1 (enExample) |
| WO (1) | WO2015181728A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2949932C (en) * | 2014-05-27 | 2021-08-10 | Rhizen Pharmaceuticals Sa | Improved forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations |
| MX2018014577A (es) | 2016-05-27 | 2019-05-20 | Tg Therapeutics Inc | Combinacion de anticuerpo anti-cd20, inhibidor selectivo de quinasa p13-delta, e inhibidor de btk para tratar trastornos proliferativos de celulas b. |
| MX2019002728A (es) | 2016-09-09 | 2019-08-16 | Tg Therapeutics Inc | Combinacion de un anticuerpo anti-cd20, inhibidor de quinasa pi3-delta, y anticuerpo anti-pd-1 o anti-pd-l1 para el tratamiento hematologico de los canceres. |
| WO2021009509A1 (en) | 2019-07-15 | 2021-01-21 | Johnson Matthey Public Limited Company | Amorphous umbralisib monotosylate |
| US20220143026A1 (en) | 2020-11-12 | 2022-05-12 | Tg Therapeutics, Inc. | Triple combination to treat b-cell malignancies |
| US11814439B1 (en) | 2022-06-01 | 2023-11-14 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11884740B1 (en) | 2022-06-01 | 2024-01-30 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11965032B1 (en) | 2022-06-01 | 2024-04-23 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11807689B1 (en) | 2022-06-01 | 2023-11-07 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02010618A (es) * | 2000-04-25 | 2004-05-05 | Icos Corp | Inhibidores de fosfatidilinositol 3-quinasa delta. |
| ES2347241T3 (es) | 2002-12-16 | 2010-10-27 | Genentech, Inc. | Variantes de inmunoglobulina y sus utilizaciones. |
| WO2005016348A1 (en) | 2003-08-14 | 2005-02-24 | Icos Corporation | Method of inhibiting immune responses stimulated by an endogenous factor |
| NZ631024A (en) | 2008-11-13 | 2016-04-29 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| SG174529A1 (en) | 2009-03-24 | 2011-10-28 | Gilead Calistoga Llc | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| PT2421536E (pt) | 2009-04-20 | 2015-10-20 | Gilead Calistoga Llc | Métodos de tratamento para tumores sólidos |
| KR101988079B1 (ko) | 2012-07-04 | 2019-06-11 | 리젠 파마슈티컬스 소시에떼 아노님 | 선택적 pi3k 델타 억제제 |
| CA2949932C (en) * | 2014-05-27 | 2021-08-10 | Rhizen Pharmaceuticals Sa | Improved forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations |
-
2015
- 2015-05-26 CA CA2949932A patent/CA2949932C/en active Active
- 2015-05-26 EP EP21182208.5A patent/EP3971188A1/en not_active Withdrawn
- 2015-05-26 CN CN201580034288.7A patent/CN106661030B/zh not_active Expired - Fee Related
- 2015-05-26 DK DK15733532.4T patent/DK3149000T3/da active
- 2015-05-26 WO PCT/IB2015/053940 patent/WO2015181728A1/en not_active Ceased
- 2015-05-26 PL PL15733532T patent/PL3149000T3/pl unknown
- 2015-05-26 JP JP2016569636A patent/JP6987501B2/ja not_active Expired - Fee Related
- 2015-05-26 EP EP15733532.4A patent/EP3149000B1/en active Active
- 2015-05-26 HU HUE15733532A patent/HUE054916T2/hu unknown
- 2015-05-26 RS RS20210920A patent/RS62136B1/sr unknown
- 2015-05-26 CN CN202010471226.5A patent/CN111635406A/zh active Pending
- 2015-05-26 SM SM20210532T patent/SMT202100532T1/it unknown
- 2015-05-26 KR KR1020167036318A patent/KR20170007480A/ko not_active Ceased
- 2015-05-26 PT PT157335324T patent/PT3149000T/pt unknown
- 2015-05-26 BR BR112016027674A patent/BR112016027674A2/pt not_active Application Discontinuation
- 2015-05-26 SI SI201531656T patent/SI3149000T1/sl unknown
- 2015-05-26 AU AU2015265542A patent/AU2015265542B2/en not_active Ceased
- 2015-05-26 EA EA201692255A patent/EA032506B1/ru unknown
- 2015-05-26 LT LTEPPCT/IB2015/053940T patent/LT3149000T/lt unknown
- 2015-05-26 HR HRP20211151TT patent/HRP20211151T1/hr unknown
- 2015-05-26 ES ES15733532T patent/ES2880999T3/es active Active
- 2015-05-26 US US15/313,454 patent/US9969740B2/en active Active
-
2016
- 2016-11-20 IL IL249058A patent/IL249058B2/en unknown
-
2018
- 2018-04-11 US US15/950,606 patent/US10414773B2/en active Active
-
2019
- 2019-08-30 US US16/557,091 patent/US10947244B2/en not_active Expired - Fee Related
-
2020
- 2020-05-20 JP JP2020088147A patent/JP2020122022A/ja active Pending
- 2020-12-23 US US17/247,806 patent/US20210269446A1/en not_active Abandoned
-
2021
- 2021-07-21 CY CY20211100652T patent/CY1124316T1/el unknown
-
2022
- 2022-04-05 JP JP2022062937A patent/JP2022082680A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017516785A5 (enExample) | ||
| JP2019163290A5 (enExample) | ||
| JP7749642B2 (ja) | Ｒｅｔｒｏｖｉｒｉｄａｅウイルス感染の処置において有用な治療用化合物を調製するための方法および中間体 | |
| HRP20171610T1 (hr) | Selektivni inhibitori pi3k delta | |
| JP2017505808A5 (enExample) | ||
| HRP20211151T1 (hr) | Kristalinska tosilatna sol pi3k delta selektivnog inhibitora za uporabu u farmaceutskim formulacijama | |
| JP2024166311A (ja) | 化合物、組成物、及び、方法 | |
| JP2017501234A5 (enExample) | ||
| JP2018511634A5 (enExample) | ||
| JP2025505112A (ja) | ベンゾピリミジン化合物及びその使用 | |
| JP2019518071A5 (enExample) | ||
| JP2019515952A5 (enExample) | ||
| JP2018520205A5 (enExample) | ||
| JP2013525433A5 (enExample) | ||
| JP2020519654A5 (enExample) | ||
| JP2016128501A5 (enExample) | ||
| JP2016537346A5 (enExample) | ||
| JP2013502396A5 (enExample) | ||
| JP2013525448A5 (enExample) | ||
| TW201609679A (zh) | 磷脂酸肌醇-3-激酶抑制劑的製造方法 | |
| CN119110801A (zh) | 选择性抑制parp1的氟代喹喔啉酮衍生物 | |
| JP2010529986A5 (enExample) | ||
| JP2019520321A5 (enExample) | ||
| JP2018520147A5 (enExample) | ||
| JP2018502083A5 (enExample) |